Phenotypic characterisation of Human Immunodeficiency Virus type 1 Envelope entry efficiency of transmitted/founder variants circulating in Mbeya, Tanzania

Zenda Loren Woodman, Philippe Selhorst‎, Andile Nofemela, Gama Bandawe, Michael Hoelscher, Leonard Maboko, Jinny Marais


Background:  Altered fitness of transmitted founder (T/F) HIV-1 variants has been linked to slowed disease progression, yet almost all of these studies have focussed on the role of attenuating immune escape mutations in T/F Gag or entry efficiency of Envelope (Env) in long-term non-progressors (LTNP) and elite suppressors (ES) during chronic stages of infection. As Env could also play an important role in viral fitness during early infection, we investigated if T/F Env entry efficiency, prior to immune selection, affected viral loads of progressors in vivo.  

Findings: Functional Env clones from eight progressors and one LTNP, representing the T/F virus responsible for clinical infection, were constructed. Subsequently Env pseudoviruses (PSVs) were generated, and confirmed to be all R5 but not macrophage tropic. PSVs had a ~80 fold range in entry efficiencies using TZM-bl cells with the LTNP being the poorest enterer. Enhanced entry was associated with increased viral load at 3 months although this association was reduced by 12 months. Finally, we show that entry efficiency was influenced by fusion capacity, CCR5/CD4 dependency, and/or incorporation of gp120 into pseudovirions.

Conclusion:  The variation in TZM-bl entry efficiency of T/F viruses was due to one or more advantageous Env attributes. Viruses with high entry efficiency may have a replication advantage subsequent to transmission, leading to increased viral loads during early infection of progressors.


HIV, transmission, entry efficiency, disease progression

Full Text:


Abrahams, M. R., J. A. Anderson, E. E. Giorgi, C. Seoighe, K. Mlisana, L. H. Ping, G. S. Athreya, F. K. Treurnicht, B. F. Keele, N. Wood, J. F. Salazar-Gonzalez, T. Bhattacharya, H. Chu, I. Hoffman, S. Galvin, C. Mapanje, P. Kazembe, R. Thebus, S. Fiscus, W. Hide, M. S. Cohen, S. A. Karim, B. F. Haynes, G. M. Shaw, B. H. Hahn, B. T. Korber, R. Swanstrom, C. Williamson, C. A. I. S. Team and H. I. V. A. V. I. C. Center for (2009). "Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants." J Virol 83(8): 3556-3567.

Alexander, M., R. Lynch, J. Mulenga, S. Allen, C. A. Derdeyn and E. Hunter (2010). "Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry." J Virol 84(8): 4100-4104.

Bachrach, E., H. Dreja, Y. L. Lin, C. Mettling, V. Pinet, P. Corbeau and M. Piechaczyk (2005). "Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells." Virology 332(1): 418-429.

Ball, S. C., A. Abraha, K. R. Collins, A. J. Marozsan, H. Baird, M. E. Quinones-Mateu, A. Penn-Nicholson, M. Murray, N. Richard, M. Lobritz, P. A. Zimmerman, T. Kawamura, A. Blauvelt and E. J. Arts (2003). "Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and C." Journal of Virology 77(2): 1021-1038.

Burgers, W. A., J. H. van Harmelen, E. Shephard, C. Adams, T. Mgwebi, W. Bourn, T. Hanke, A. L. Williamson and C. Williamson (2006). "Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial." J Gen Virol 87(Pt 2): 399-410.

Casado, C., S. Colombo, A. Rauch, R. Martinez, H. F. Gunthard, S. Garcia, C. Rodriguez, J. Del Romero, A. Telenti and C. Lopez-Galindez (2010). "Host and viral genetic correlates of clinical definitions of HIV-1 disease progression." PLoS One 5(6): e11079.

Casado, C., M. Pernas, V. Sandonis, T. Alvaro-Cifuentes, I. Olivares, R. Fuentes, L. Martinez-Prats, E. Grau, L. Ruiz, R. Delgado, C. Rodriguez, J. del Romero and C. Lopez-Galindez (2013). "Identification of a cluster of HIV-1 controllers infected with low replicating viruses." PLoS One 8(10): e77663.

Chopera, D. R., Z. Woodman, K. Mlisana, M. Mlotshwa, D. P. Martin, C. Seoighe, F. Treurnicht, D. A. de Rosa, W. Hide, S. A. Karim, C. M. Gray, C. Williamson and C. S. Team (2008). "Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage." PLoS Pathog 4(3): e1000033.

Cilliers, T., P. Moore, M. Coetzer and L. Morris (2005). "In vitro generation of HIV type 1 subtype C isolates resistant to enfuvirtide." AIDS Res Hum Retroviruses 21(9): 776-783.

Fouda, G. G., T. Mahlokozera, J. F. Salazar-Gonzalez, M. G. Salazar, G. Learn, S. B. Kumar, S. M. Dennison, E. Russell, K. Rizzolo, F. Jaeger, F. Cai, N. A. Vandergrift, F. Gao, B. Hahn, G. M. Shaw, C. Ochsenbauer, R. Swanstrom, S. Meshnick, V. Mwapasa, L. Kalilani, S. Fiscus, D. Montefiori, B. Haynes, J. Kwiek, S. M. Alam and S. R. Permar (2013). "Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants." Retrovirology 10: 3.

Goepfert, P. A., W. Lumm, P. Farmer, P. Matthews, A. Prendergast, J. M. Carlson, C. A. Derdeyn, J. Tang, R. A. Kaslow, A. Bansal, K. Yusim, D. Heckerman, J. Mulenga, S. Allen, P. J. Goulder and E. Hunter (2008). "Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients." J Exp Med 205(5): 1009-1017.

Haaland, R. E., P. A. Hawkins, J. Salazar-Gonzalez, A. Johnson, A. Tichacek, E. Karita, O. Manigart, J. Mulenga, B. F. Keele, G. M. Shaw, B. H. Hahn, S. A. Allen, C. A. Derdeyn and E. Hunter (2009). "Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1." PLoS Pathog 5(1): e1000274.

Herbinger, K. H., M. Gerhardt, S. Piyasirisilp, D. Mloka, M. A. Arroyo, O. Hoffmann, L. Maboko, D. L. Birx, D. Mmbando, F. E. McCutchan and M. Hoelscher (2006). "Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania." AIDS Res Hum Retroviruses 22(7): 599-606.

Keele, B. F., E. E. Giorgi, J. F. Salazar-Gonzalez, J. M. Decker, K. T. Pham, M. G. Salazar, C. Sun, T. Grayson, S. Wang, H. Li, X. Wei, C. Jiang, J. L. Kirchherr, F. Gao, J. A. Anderson, L. H. Ping, R. Swanstrom, G. D. Tomaras, W. A. Blattner, P. A. Goepfert, J. M. Kilby, M. S. Saag, E. L. Delwart, M. P. Busch, M. S. Cohen, D. C. Montefiori, B. F. Haynes, B. Gaschen, G. S. Athreya, H. Y. Lee, N. Wood, C. Seoighe, A. S. Perelson, T. Bhattacharya, B. T. Korber, B. H. Hahn and G. M. Shaw (2008). "Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection." Proc Natl Acad Sci U S A 105(21): 7552-7557.

Kong, X., J. T. West, H. Zhang, D. M. Shea, J. M'Soka T and C. Wood (2008). "The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses." J Virol 82(23): 11609-11618.

Lassen, K. G., M. A. Lobritz, J. R. Bailey, S. Johnston, S. Nguyen, B. Lee, T. Chou, R. F. Siliciano, M. Markowitz and E. J. Arts (2009). "Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics." PLoS Pathog 5(4): e1000377.

Li, M., F. Gao, J. R. Mascola, L. Stamatatos, V. R. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, P. Gilbert, K. M. Greene, M. Bilska, D. L. Kothe, J. F. Salazar-Gonzalez, X. Wei, J. M. Decker, B. H. Hahn and D. C. Montefiori (2005). "Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies." J Virol 79(16): 10108-10125.

Marozsan, A. J., D. M. Moore, M. A. Lobritz, E. Fraundorf, A. Abraha, J. D. Reeves and E. J. Arts (2005). "Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry." J Virol 79(11): 7121-7134.

Martinez-Picado, J., J. G. Prado, E. E. Fry, K. Pfafferott, A. Leslie, S. Chetty, C. Thobakgale, I. Honeyborne, H. Crawford, P. Matthews, T. Pillay, C. Rousseau, J. I. Mullins, C. Brander, B. D. Walker, D. I. Stuart, P. Kiepiela and P. Goulder (2006). "Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1." J Virol 80(7): 3617-3623.

Miura, T., Z. L. Brumme, M. A. Brockman, P. Rosato, J. Sela, C. J. Brumme, F. Pereyra, D. E. Kaufmann, A. Trocha, B. L. Block, E. S. Daar, E. Connick, H. Jessen, A. D. Kelleher, E. Rosenberg, M. Markowitz, K. Schafer, F. Vaida, A. Iwamoto, S. Little and B. D. Walker (2010). "Impaired replication capacity of acute/early viruses in persons who become HIV controllers." J Virol 84(15): 7581-7591.

Nofemela, A., G. Bandawe, R. Thebus, J. Marais, N. Wood, O. Hoffmann, L. Maboko, M. Hoelscher, Z. Woodman and C. Williamson (2011). "Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms." Virology 415(2): 107-113.

Ochsenbauer, C., T. G. Edmonds, H. Ding, B. F. Keele, J. Decker, M. G. Salazar, J. F. Salazar-Gonzalez, R. Shattock, B. F. Haynes, G. M. Shaw, B. H. Hahn and J. C. Kappes (2012). "Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages." J Virol 86(5): 2715-2728.

Parker, Z. F., S. S. Iyer, C. B. Wilen, N. F. Parrish, K. C. Chikere, F. H. Lee, C. A. Didigu, R. Berro, P. J. Klasse, B. Lee, J. P. Moore, G. M. Shaw, B. H. Hahn and R. W. Doms (2013). "Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5." J Virol 87(5): 2401-2411.

Parrish, N. F., F. Gao, H. Li, E. E. Giorgi, H. J. Barbian, E. H. Parrish, L. Zajic, S. S. Iyer, J. M. Decker, A. Kumar, B. Hora, A. Berg, F. Cai, J. Hopper, T. N. Denny, H. Ding, C. Ochsenbauer, J. C. Kappes, R. P. Galimidi, A. P. West, Jr., P. J. Bjorkman, C. B. Wilen, R. W. Doms, M. O'Brien, N. Bhardwaj, P. Borrow, B. F. Haynes, M. Muldoon, J. P. Theiler, B. Korber, G. M. Shaw and B. H. Hahn (2013). "Phenotypic properties of transmitted founder HIV-1." Proc Natl Acad Sci U S A 110(17): 6626-6633.

Ping, L. H., S. B. Joseph, J. A. Anderson, M. R. Abrahams, J. F. Salazar-Gonzalez, L. P. Kincer, F. K. Treurnicht, L. Arney, S. Ojeda, M. Zhang, J. Keys, E. L. Potter, H. Chu, P. Moore, M. G. Salazar, S. Iyer, C. Jabara, J. Kirchherr, C. Mapanje, N. Ngandu, C. Seoighe, I. Hoffman, F. Gao, Y. Tang, C. Labranche, B. Lee, A. Saville, M. Vermeulen, S. Fiscus, L. Morris, S. A. Karim, B. F. Haynes, G. M. Shaw, B. T. Korber, B. H. Hahn, M. S. Cohen, D. Montefiori, C. Williamson, R. Swanstrom, C. A. I. Study and H. I. V. A. V. I. C. the Center for (2013). "Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design." J Virol 87(13): 7218-7233.

Poncelet, P., G. Poinas, P. Corbeau, C. Devaux, N. Tubiana, N. Muloko, C. Tamalet, J. C. Chermann, F. Kourilsky and J. Sampol (1991). "Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease." Res Immunol 142(4): 291-298.

Prince, J. L., D. T. Claiborne, J. M. Carlson, M. Schaefer, T. Yu, S. Lahki, H. A. Prentice, L. Yue, S. A. Vishwanathan, W. Kilembe, P. Goepfert, M. A. Price, J. Gilmour, J. Mulenga, P. Farmer, C. A. Derdeyn, J. Tang, D. Heckerman, R. A. Kaslow, S. A. Allen and E. Hunter (2012). "Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis." PLoS Pathog 8(11): e1003041.

Provine, N. M., W. B. Puryear, X. Wu, J. Overbaugh and N. L. Haigwood (2009). "The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity." J Virol 83(17): 9002-9007.

Quinones-Mateu, M. E., S. C. Ball, A. J. Marozsan, V. S. Torre, J. L. Albright, G. Vanham, G. van Der Groen, R. L. Colebunders and E. J. Arts (2000). "A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression." J Virol 74(19): 9222-9233.

Rangel, H. R., J. Weber, B. Chakraborty, A. Gutierrez, M. L. Marotta, M. Mirza, P. Kiser, M. A. Martinez, J. A. Este and M. E. Quinones-Mateu (2003). "Role of the human immunodeficiency virus type 1 envelope gene in viral fitness." J Virol 77(16): 9069-9073.

Riedner, G., O. Hoffmann, M. Rusizoka, D. Mmbando, L. Maboko, H. Grosskurth, J. Todd, R. Hayes and M. Hoelscher (2006). "Decline in sexually transmitted infection prevalence and HIV incidence in female barworkers attending prevention and care services in Mbeya Region, Tanzania." AIDS 20(4): 609-615.

Salazar-Gonzalez, J. F., M. G. Salazar, B. F. Keele, G. H. Learn, E. E. Giorgi, H. Li, J. M. Decker, S. Wang, J. Baalwa, M. H. Kraus, N. F. Parrish, K. S. Shaw, M. B. Guffey, K. J. Bar, K. L. Davis, C. Ochsenbauer-Jambor, J. C. Kappes, M. S. Saag, M. S. Cohen, J. Mulenga, C. A. Derdeyn, S. Allen, E. Hunter, M. Markowitz, P. Hraber, A. S. Perelson, T. Bhattacharya, B. F. Haynes, B. T. Korber, B. H. Hahn and G. M. Shaw (2009). "Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection." J Exp Med 206(6): 1273-1289.

Song, H., J. W. Pavlicek, F. Cai, T. Bhattacharya, H. Li, S. S. Iyer, K. J. Bar, J. M. Decker, N. Goonetilleke, M. K. Liu, A. Berg, B. Hora, M. S. Drinker, J. Eudailey, J. Pickeral, M. A. Moody, G. Ferrari, A. McMichael, A. S. Perelson, G. M. Shaw, B. H. Hahn, B. F. Haynes and F. Gao (2012). "Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome." Retrovirology 9: 89.

Travers, S. A., M. J. O'Connell, G. P. McCormack and J. O. McInerney (2005). "Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes." J Virol 79(3): 1836-1841.

van Harmelen, J., C. Williamson, B. Kim, L. Morris, J. Carr, S. S. Karim and F. McCutchan (2001). "Characterization of full-length HIV type 1 subtype C sequences from South Africa." AIDS Res Hum Retroviruses 17(16): 1527-1531.

Williamson, C., L. Morris, M. F. Maughan, L. H. Ping, S. A. Dryga, R. Thomas, E. A. Reap, T. Cilliers, J. van Harmelen, A. Pascual, G. Ramjee, G. Gray, R. Johnston, S. A. Karim and R. Swanstrom (2003). "Characterization and selection of HIV-1 subtype C isolates for use in vaccine development." AIDS Res Hum Retroviruses 19(2): 133-144.

Yue, L., K. J. Pfafferott, J. Baalwa, K. Conrod, C. C. Dong, C. Chui, R. Rong, D. T. Claiborne, J. L. Prince, J. Tang, R. M. Ribeiro, E. Cormier, B. H. Hahn, A. S. Perelson, G. M. Shaw, E. Karita, J. Gilmour, P. Goepfert, C. A. Derdeyn, S. A. Allen, P. Borrow and E. Hunter (2015). "Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients." PLoS Pathog 11(1): e1004565.

DOI: http://dx.doi.org/10.18103/mra.v2i2.359


  • There are currently no refbacks.